TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Actinogen Medical ( (AU:ACW) ) has provided an update.
Actinogen Medical Limited has announced the quotation of 251,050 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of December 5, 2025. This move marks a significant step for the company, potentially enhancing its market presence and providing additional capital for its operations, which could positively impact its stakeholders.
The most recent analyst rating on (AU:ACW) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Actinogen Medical stock, see the AU:ACW Stock Forecast page.
More about Actinogen Medical
Actinogen Medical Limited operates in the biotechnology industry, focusing on the development of innovative therapies for neurological conditions.
Average Trading Volume: 4,182,301
Technical Sentiment Signal: Buy
Current Market Cap: A$175M
For an in-depth examination of ACW stock, go to TipRanks’ Overview page.